Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003
Pituitary Surgery for Acromegaly, Should be Done by Specialists
BMJ 319:588-589, Clayton,R.N.,et al, 1999
Complications of Transsphenoidal Surgery:Results of a National Survey, Review of the Literature, and Personal Experience
Neurosurg 40:225-236, Ciric,I.,et al, 1997
Arterial Injuries in Transsphenoidal Surgery for Pituitary Adenoma:The Role of Angiography and Endovascular Treatment
ANJR 18:655-665, Raymond,J.,et al, 1997
Octreotide
NEJM 334:246-254, Lamberts,S.W.J.,et al, 1996
Octreotide Treatment of Acromegaly, A Randomized, Multicenter Study
Ann Int Med 117:711-718, Ezzat,S.,et al, 1992
Long-term Treatment of 189 Acromegalic Patients with the Somatostatin Analog Octreotide
Arch Int Med 151:1573-1578, Vance,M.L.&Harris,A.G., 1991
Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984
Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998
The Long-Term Outcome of Pituitary Irradiation after Unsuccessful Transsphenoidal Surgery in Cushing's Disease
NEJM 336:172-177, 2151997., Estrada,J.,et al, 1997
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Risk of Second Brain Tumour after Conservative Surgery and Radiotherapy for Pituitary Adenoma
BMJ 304:1343-1346, Brada,M.,et al, 1992
Delayed Radiation Necrosis of the CNS in Patients Irradiated for Pituitary Tumours
JNNP 55:949-955, Grattan-Smith,P.J.,et al, 1992
Primary Radiotherapy of Prolactinomas, Eight-to 15-Year Follow-Up
Am J Med 83:49-58, Mehta,A.E.,et al, 1987
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Mixed Intracranial Sarcomas:Rare Forms & a New Association with Previous Radiation Therapy
Ann Neurol 4:229-223, Averback,P., 1978